🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate if Non-Ischemic Heart Preservation...
Status
Recruiting
Location
UC San Diego Health
Start Date
2025-07-10
Trial ID
NCT06895070
Treatments Being Tested
The purpose of this study is to evaluate the long-term safety and the clini...
Status
Recruiting
Location
University of California LA
Start Date
2024-08-13
Trial ID
NCT06401356
Treatments Being Tested
PRF110 is new extended release oily solution formulation of ropivacaine tha...
Status
Unknown
Location
The Chaim Sheba Medical Center
Start Date
2016-08
Trial ID
NCT02784327
Treatments Being Tested
The objectives were: (1) To demonstrate the efficacy of adalimumab in the l...
Status
Completed
Location
Gastroenterology Associates of the East Bay
Start Date
2002-08
Trial ID
NCT01070303
Treatments Being Tested
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate t...
Status
Recruiting
Location
UZ Leuven
Start Date
2026-08
Trial ID
NCT07587242
The purposes of the study is to determine if LiRIS®, an investigational dru...
Status
Terminated
Location
Citrus Valley Medical Research , Inc.
Start Date
2013-03
Trial ID
NCT01824303
Treatments Being Tested
This open-label extension study will evaluate the long-term safety and effi...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01662063
Treatments Being Tested
The purpose of this research study is to test the safety and local toleranc...
Status
Completed
Location
Investigational site
Start Date
2014-06
Trial ID
NCT02040207
Treatments Being Tested
This is a clinical trial to determine the long-term safety and tolerability...
Status
Terminated
Location
University of Alabama at Birmingham Huntsville Regional Medical Campus
Start Date
2022-03-17
Trial ID
NCT05227209
Treatments Being Tested
This is a prospective, randomized, open-label, multicenter phase III study ...
Status
Recruiting
Location
Zhimin Cancer Shao
Start Date
2024-04-02
Trial ID
NCT06341621
Treatments Being Tested